Advertisement

Topics

Cruachem Limited Company Profile

10:29 EST 18th December 2018 | BioPortfolio

Cruachem Ltd, an Annovis Inc. company, is a leader in nucleic acid chemistry. Cruachem offers the largest range of DNA and RNA custom oligonucleotides available including oligomimetics (-molecular mimics used in antisense therapies), as well as DNA and RNA synthesis reagents and molecular biology kits. Our custom oligonucleotides are synthesised using our own high quality phosphoramidites manufactured at our ISO9000 and PSCOP registered facility is Glasgow. We provide products to over 35 countries worldwide, directly or through our network of 20 distributors. Thanks to our vast experience with nucleic acid chemistry, we can also offer contract nucleic acid production services from R & D scale, through scale-up, to Kg scale manufacturing.

Location

United Kingdom


News Articles [32 Associated News Articles listed on BioPortfolio]

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an ...

Quotient Limited Announces Completion of Senior Secured Notes Offering

JERSEY, Channel Islands, July 02, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), has completed the offering of up to $120.0 million ...

Quotient Limited Announces Initial MosaiQ™ SDS Verification and Validation Data

JERSEY, Channel Islands, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported positive Verification and Validation...

Quotient Limited to Participate in the Jefferies 2018 London Healthcare Conference

JERSEY, Channel Islands, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chief Financial Officer, Chris Lindop,...

Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of its previously annou...

Quotient Limited to Participate in the 2018 Cantor Fitzgerald Global Healthcare Conference

JERSEY, Channel Islands, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, ...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [87 Associated Companies listed on BioPortfolio]

Cruachem Limited

Cruachem Ltd, an Annovis Inc. company, is a leader in nucleic acid chemistry. Cruachem offers the largest range of DNA and RNA custom oligonucleotides available including oligomimetics (-molecular mi...

Transgenomics Incorporated

Cruachem Ltd is a leader in nucleic acid chemistry. We offer custom DNA and RNA oligonucleotides, DNA and RNA synthesis reagents, and contract nucleic acid manufacturing from R & D scale to Kg scale.

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

More Information about "Cruachem Limited" on BioPortfolio

We have published hundreds of Cruachem Limited news stories on BioPortfolio along with dozens of Cruachem Limited Clinical Trials and PubMed Articles about Cruachem Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cruachem Limited Companies in our database. You can also find out about relevant Cruachem Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Antisense therapy
Most human diseases are caused by production of abnormal proteins or malfunctioning proteins.   Antisense therapy involves inhibiting production of these proteins.  When a gene is known to cause a specific disease and the genetic sequence ...


Corporate Database Quicklinks



Searches Linking to this Company Record